Biotech Stock News: Biogen’s Q2 Earnings leads to a Stock Rise

Biogen Idec (BIIB) reported second quarter 2014 earnings per share of $3.48 (including the impact of stock-based compensation expense), way above the Consensus Estimate of $2.80 and the year-ago earnings of $2.29 per share. While oral multiple sclerosis (MS) drug, Tecfidera contributed significantly to revenues, the company also benefited from the approval of an agreement…

Read More

Hot Alert : International Business Machines (NYSE:IBM), Peabody Energy (NYSE:BTU), Guidewire Software (NYSE:GWRE), TransAct Technologies (NASDAQ:TACT), Facebook (NASDAQ:FB)

A few weeks back, Apple (AAPL) and International Business Machines Corporation (NYSE:IBM) entered into a partnership in which IBM would be able to analyze the data collected from Apple’s devices. The purpose of the partnership is to create 100 mobile apps specifically for enterprise customers. Through this partnership, Apple hopes that its iPad and iPhone…

Read More
Home